GLP1R and type 2 diabetes mellitus: In this exploratory study, we aimed to assess the effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients in an untargeted peptidomics approach, aiming to ultimately shed some light on the underlying molecular mechanisms defining response.